Stem Cell Research on Cardiology

• Altri autori: David, Robert (Redattore)
• Natura: Elettronico Capitolo di libro
• Lingua: inglese
• Pubblicazione: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
• Soggetti: Research & information: general; Biology, life sciences; Fabry disease; human embryonic stem cells; CRISPR/Cas9 genomic editing; Mass spectrometry proteomic analysis; hypertrophic cardiomyopathy; disease model; physical exercise; cardiac cellular regeneration; microRNA (miR); Akt signaling; cardiomyocyte proliferation; cardiac hypertrophy; cardioprotection; myocarditis; inflammation; leukocytes; cardiomyocytes; multi-electrode-array; micro-electrode-array; MEA; drug/toxicity screening; field potential; arrhythmia; electrocardiography; cardiac regeneration; stem cells; iPSC; PSC; ESC; cardiovascular disease; regeneration; cardiac progenitor cells; induced pluripotent stem cells; transdifferentiation; direct reprogramming; genetic engineering; cardiac tissue engineering; biomaterials; 18F-FDG PET; cardiac induced cells; cardiac function; non-invasive imaging; human pluripotent stem cell; ventricular; maturation; bone marrow stem cells; angiogenesis; myocardial infarction; human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs); iPS cells; big conductance calcium activated potassium channel (BK); Maxi-K; slo1; KCa1.1; iberiotoxin; long QT syndrome; mesenchymal stromal cells (MSC); mRNA; miRNA; cardiac reprogramming; cardiac differentiation; cardiovascular diseases; adult stem cells; myocardial infraction; 3D printing; 3D model; bioprinting; cardiovascular medicine; heart; myocardium; heart valves; vascular graft; endothelialization; tissue engineering; decorin; fibronectin; electrospinning; endothelial progenitor cells; bioreactor; biostable polyurethane; MicroRNA; Mir-133; coronary heart disease; biomarker; meta-analysis
• Accesso online: DOAB: download the publication; DOAB: description of the publication

Even today, cardiovascular diseases are the main cause of death worldwide, and therapeutic approaches are very restricted. Due to the limited regenerative capabilities of terminally differentiated cardiomyocytes post injury, new strategies to treat cardiac patients are urgently needed. Post myocardi...